Gabriela Hobbs/LinkedIn, Andrew Kuykendall/ moffitt.org, Yu-Han Chen/LinkedIn
Jul 4, 2026, 12:24
Gabriela Hobbs: Outcomes of MPN Patients with Concurrent Driver Mutations
Gabriela Hobbs, Leukemia Clinical Director at Massachusetts General Hospital, Associate Professor at Harvard Medical School, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Neoplasia, adding:
“Congrats Yu-Han Chen for this publication describing outcomes of MPN pts with concurrent MPL and JAK2/CALR mutations!
Thank you Andrew Kuykendall for the collaboration and ASH HIP program for their support!”
Title: Clinical features and outcomes of MPN with concurrent MPL and JAK2/CALR Mutations
Authors: Yu-Han Chen, Shruti Gajjar, Victor You, Rami Komrokji, Valentina Nardi, Harrison Tsai, Zhuoer Xie, Andrew Kuykendall, Gabriela S Hobbs
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC